italiano english 
Toscana Biomarkers è un'azienda strat-up residente all'interno del bio-incubator della Fondazione Toscana Life Sciences 
Azienda Spin-off dell'Università di Pisa
 
Toscana Biomarkers Srl
Via Fiorentina 1
I-53100 Siena, Italy
Phone: +39 0577 231271/2
Fax: +39 0577 274107
Capitale Sociale euro 100.000,00 i.v.
Registro d'impresa di Siena, C.F.
e P.IVA 02042930970
R.E.A. Siena 128830
info@toscanabiomarkers.com

 

Test

Autoimmune disorders are diagnosed, evaluated, and monitored through a combination of autoantibody blood tests, blood tests to measure inflammation and organ function, clinical presentation, and MRI examinations.

In vitro tests based on the detection of antibodies as disease biomarkers can be efficiently used for the diagnosis and the follow-up of autoimmune disorders. Antibody-titer can be evaluated using different techniques, such as Enzyme-Linked ImmunoSorbent Assay (ELISA).


The efficacy of a diagnostic/prognostic test relies in the selection of a specific and selective biomarker, which can be univocally biochemically characterized. In this sense, peptides can provide reproducible tools for antibody monitoring.